In our previous Japanese cohort study of patients with EGFR mutant lung cancer, high HGF expression was detected in 61% of tumors with acquired resistance and in 29% of tumors with intrinsic resistance to EGFR-TKIs, suggesting that targeting HGF may overcome resistance to EGFR-TKIs [25]. Here, EGFR is linked to lung cancer.